肝脏 ›› 2022, Vol. 27 ›› Issue (5): 540-542.

• 肝纤维化及肝硬化 • 上一篇    下一篇

酒精性肝硬化的肝移植受者血小板减少的病例对照研究

冯丹妮, 张达利, 贺希, 张利娟, 周双男, 高银杰, 刘鸿凌   

  1. 100039 北京 解放军总医院第五医学中心肝病医学部
  • 收稿日期:2021-07-26 出版日期:2022-05-31 发布日期:2022-07-13
  • 通讯作者: 刘鸿凌,Email:lhl7125@sina.com
  • 基金资助:
    北京市科委项目(Z161100000116058)

Case-control study of thrombocytopenia in liver transplant recipients with alcoholic cirrhosis

FENG Dan-ni, ZHANG Da-li, HE Xi, ZHANG Li-juan, ZHOU Shuang-nan, GAO Yin-jie, LIU Hong-ling   

  1. Department of Liver Disease, The 5th Medical Center, Chinese People′s Liberation Army (PLA) General Hospital, Beijing 100039, China
  • Received:2021-07-26 Online:2022-05-31 Published:2022-07-13
  • Contact: LIU Hong-ling, Email: lhl7125@sina.com

摘要: 目的 探究肝移植术后血小板减少的危险因素。方法 选择2015年4月至2018年11月于解放军总医院第五医学中心因酒精性肝硬化行肝移植患者38例。肝移植术后1年时血小板水平低于100×109/L的患者为9例,肝移植术后1年时血小板正常29例。观察暴露因素低密度脂蛋白水平与脾脏面积对术后血小板水平的影响。2组间比较采用t检验或非参数检验。应用logistic回归分析危险因素。结果 肝移植术后1年时血小板水平下降9例患者,血小板水平为86.0(76.0, 89.0)×109/L,29例血小板正常患者,血小板水平为129.0(118.0, 166.0)×109/L。血小板下降患者占23.68% (9/38)。血小板减少组和正常组患者术前血小板水平分别为35±5.47 ×109/L、 47(35, 61) ×109/L(Z=-2.04,P=0.041)、术前低密度脂蛋白水平分别为0.86(0.82,1.29) mmol/L、1.53(1.3, 2.34) mmol/L(Z=-2.68,P=0.006),术前脾脏面积分别为 6130±806.9 mm2、4410(3288, 5278.5) mm2(Z=-2.05,P=0.041)。logistic回归分析提示术前低密度脂蛋白水平下降(OR=0.089, 95%CI: 0.012-0.675, P=0.019)、术前脾脏面积大(OR=1.001, 95%CI: 1.000-1.001, P=0.024)是酒精性肝硬化患者术后血小板减少的危险因素。结论 术前血脂代谢异常和脾大可能会影响肝移植术后血小板水平。

关键词: 酒精性肝硬化, 肝移植术后, 血小板减少, 危险因素

Abstract: Objective To investigate whether pre-liver transplantation (LT) low low-density lipoprotein (LDL) level and pre-LT large spleen size were the risk factors for thrombocytopenia after LT. Methods A total of 81 patients who underwent LT for alcoholic cirrhosis in our hospital from April 2015 to November 2018 were enrolled. Patients with thrombocytopenia after LT were screened. Patients with platelet (PLT) level less than 100 × 109/L and more than 100 × 109/L in 1 year after LT were selected into case group and control group, respectively. The influence of pre-LT LDL level and spleen size on post-LT PLT level was recorded. The averages of the 2 groups were compared by t test and non-parametric test. Logistic regression was used to analyze risk factors. Results Finally, 38 liver recipients met the inclusion criteria were enrolled. In the first year after LT, the PLT level of 9 patients decreased (case group), with the median of 86.0 (76.0, 89.0) ×109/L, while 29 cases with normal PLT level (control group), with the median of 129.0 (118.0, 166.0) ×109/L. Compared with control group, patients in case group had significant lower pre-LT PLT level (35±5.47×109/L, 47(35, 61)×109/L, respectively, Z=-2.04, P=0.041), lower pre-LT LDL level (0.86(0.82,1.29) mmol/L, 1.53(1.3, 2.34) mmol/L, Z=-2.68, P=0.006) and larger spleen size (6130±806.9 mm2, 4410(3288, 5278.5) mm2, Z=-2.05, P=0.041). Logistic regression analysis showed that lower pre-LT LDL level (OR=0.089, 95%CI: 0.012 - 0.675, P=0.019)) and large spleen size (OR=1.001, 95% CI: 1.000-1.001,P=0.024) were risk factors for thrombocytopenia after LT. Conclusion Low pre-LT LDL level and splenomegaly may induce thrombocytopenia after LT.

Key words: Alcoholic cirrhosis, Post liver transplantation, Thrombocytopenia, Risk factor